Sex differences in the effectiveness of first-line tumor necrosis factor inhibitors in axial spondyloarthritis; results from fifteen countries in the European spondyloarthritis (EuroSpA) research collaboration network
Pasoon Hellamand, Marleen G H Van de Sande, Lykke Midtbøll Ørnbjerg, Thomas Klausch, Michael Nurmohamed, R Van Vollenhoven, D.C. Nordström, Anna-Mari Hokkanen, MJ Santos, Elsa Vieira-Sousa, A. G. Loft, Bente Glintborg, Merete Lund Hetland, U Lindström, Johan Karlsson Wallman, Martin Michelsen, Adrian Ciurea, Michael J Nissen, Catalin Codreanu, C MoogosanGary J Macfarlane, Gareth T Jones, Karin Laas, Z Roter, M Tomsic, I Castrejon, M Pombo-Suarez, B Gudbjörnsson, Arni Jon Geirsson, Eirik K. Kristianslund, Jirí Vencovský, Lucie Nekvindova, B Zengin, Seth Guller, Mikkel Østergaard, I Van der Horst- Bruinsma
Dyk ned i forskningsemnerne om 'Sex differences in the effectiveness of first-line tumor necrosis factor inhibitors in axial spondyloarthritis; results from fifteen countries in the European spondyloarthritis (EuroSpA) research collaboration network'. Sammen danner de et unikt fingeraftryk.